Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has announcements × Lymphoma × selpercatinib × Clear all

Sponsor

Conditions

Carcinoma, Medullary 3 Thyroid Neoplasms 2 Thyroid Diseases 2 Thyroid Cancer, Papillary 2 Thoracic Neoplasms 2 Respiratory Tract Neoplasms 2 Respiratory Tract Diseases 2 Neoplasms by Site 2 Neoplasms 2 Lung Neoplasms 2 Lung Diseases 2 Head and Neck Neoplasms 2 Endocrine System Diseases 2 Endocrine Gland Neoplasms 2 Colonic Neoplasms 2 Central Nervous System Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Bronchogenic 2 Bronchial Neoplasms 2 Breast Neoplasms 2 Sarcoma 1 Myofibromatosis 1

Interventions

Rituximab 4 Lenalidomide 2 Bendamustine Hydrochloride 2 polatuzumab vedotin 1 pirtobrutinib 1 obinutuzumab 1 idelalisib 1 Vincristine 1 Prednisone 1 Fluid Therapy 1 Doxorubicin 1 Cyclophosphamide 1 Crizotinib 1 Brentuximab Vedotin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡